AstraZeneca PLC is 73.7x more valuable than Veradermics, Inc by market capitalization ($286.27 B vs $3.88 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MANE | AZN |
|---|---|---|
| Market cap | $3.88 B | $286.27 B |
| US-listed rank | #1593 | #45 |
| Net income (latest FY) | -$70.00M | - |
| SEC filings | 73 | 1,004 |
AstraZeneca PLC is 73.7x more valuable than Veradermics, Inc by market capitalization ($286.27 B vs $3.88 B).
Full pages: Veradermics, Inc and AstraZeneca PLC, or browse the full rankings.